eISSN: 1994-4624 / ISSN: 1813-176x
Register
Login
International Journal of Molecular Medicine and Advance Sciences
2006, Volume 2, Issue 1 : 96-102 doi: ijmmas.2006.96.102
Research Article
Is the Hypertensive State an Integral Etiopathogenesis Centrally Involving Vascular Myofiber Ischemia?
Published
Sept. 30, 2005
Abstract

One might strictly recognize the essential hypertensive state as a form of evolving influence, itself both a cause and an effect of integral pathways of etiopathogenesis in vascular myofiber hypercontractility and vascular myofiber ischemia.  Indeed, perhaps it is in terms of a circulatory hemodynamic disturbance that evolves both in terms primarily of myocardial hypertrophy and of vascular smooth myofiber hypercontractility that one would best understand the sustained series of both phasic and tonic responses to various systems of influence in inducing progression of the hypertensive state. Even in terms that would go beyond simple threshold considerations of such myofiber responsiveness or of myofiber contractility, the essential hypertensive state might primarily arise and evolve simply as one pathway of ischemic events that somehow progresses as positive feedback systems.  Indeed, ischemia in hypertension would beget even more ischemia that evolves in terms of parameters that are themselves inherently not related to the hypertensive state.  Indeed, ischemic organ events in arterial hypertension might evolve via systems ranging from hypercontractility of the vascular myofiber to fibrinoid necrosis of vessels, to specific vascular bed organ systems in renal failure and as systems also of intracranial hemorrhage, myocardial hypertrophy and of accelerated atherosclerosis and aneurysm formation.

Keywords
License
Copyright (c) International Journal of Molecular Medicine and Advance Sciences
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
Int. J. Mol. Med. Adv. Sci. open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Recommended Articles
Clinical Efficacy of Drug-Eluting Stents Among Hypertensive Patients
41-45
Occupational Health Risks Among Healthcare Workers: Prevalence, Determinants, Clinical Consequences, and Prevention Strategies
1-4
Healthcare Disparities and Equity in Medical Services: Challenges, Determinants, and Strategies for Achieving Equitable Healthcare
27-34
Professionalism and Ethics Education in Medical Schools: Assessing Knowledge, Attitudes, and Educational Outcomes Among Medical Students
16-20
International Journal of Molecular Medicine and Advance Sciences
+447480266638
+447480266638
support@ijmmas.com
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND) license. Open Access Publication.
Copyright © ©International Journal of Molecular Medicine and Advance Sciences. All rights reserved.